- Directors and Auditors
- Articles of Association
- General Meetings
- - Previous General Meetings
- Insider Trading
Dignitana adds five more contracts under AON agreement
Dignitana AB announces today that 5 more locations in the American Oncology Network have signed with the Company to provide The DigniCap® Scalp Cooling System to minimize hair loss from chemotherapy in patients with solid tumors.
Last month the Company signed a master agreement with American Oncology Network, the fastest growing oncology organization in the United States currently with 45 locations. The agreement provides the opportunity for any AON practice to easily provide DigniCap Scalp Cooling for their patients. Initially two AON practices in Maryland and North Carolina added DigniCap services under the new agreement and five additional locations have now signed on:
- Messino Cancer Care - Asheville, North Carolina
- Zangmeister Cancer Care - Columbus, Ohio
- Oncology/Hematology of Loudoun and Reston - Lansdowne, Virginia
- Hematology Oncology Indiana, Harcourt Road - Indianapolis, Indiana
- Hematology Oncology Indiana, Naab Road - Indianapolis, Indiana
AON is a high-growth medical oncology provider with a focus on supporting the long-term viability of oncology treatment in community-based settings. AON currently serves an expanding network of partner practices across 12 states, providing dedicated end-to-end administrative support, access to an extensive array of centralized ancillary services, and proven practice management expertise.
Dignitana is the world leader in scalp cooling innovation providing the DigniCap Scalp Cooling System in 31 states in the U.S. and 38 countries around the globe. The DigniCap Scalp Cooling System demonstrated a success rate of 66 percent in the pivotal trial for FDA clearance in 2015 and the next generation DigniCap Delta device received FDA clearance in 2019.
Melissa Bourestom, VP Corporate Communications, email@example.com +1 469 518 5031
Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001. Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Learn more at www.dignitana.se and www.dignicap.com. Eric Penser Bank AB, Certified Adviser, Box 7405,103 91 Stockholm Phone: +46 8-463 83 00 firstname.lastname@example.org www.penser.se